F.T.C. Accuses Drug Middlemen of Inflating Insulin Prices
WEB3 days ago · Sept. 20, 2024 Updated 3:16 p.m. ET. The Federal Trade Commission said on Friday that it had taken legal action against the three largest pharmacy benefit managers, accusing the drug middlemen of ...
FTC Sues Prescription Drug Middlemen for Artificially Inflating …
WEB3 days ago · Today, the Federal Trade Commission brought action against the three largest prescription drug benefit managers (PBMs)—Caremark Rx, Express Scripts (ESI), and OptumRx—and their affiliated group purchasing organizations (GPOs) for engaging in anticompetitive and unfair rebating practices that have artificially inflated the list price of …
ANALYSIS: FTC Joins States to Curb Drug Middlemen Power
WEB1 day ago · The Federal Trade Commission’s lawsuit against three of the top pharmacy benefit managers (PBMs) on Sept. 20 is the first important step the federal government has taken to try to curb the power of PBMs. With little federal action, almost half the states have enacted legislation this year to try and combat high consumer drug costs, high PBM …
The ERISA Industry Committee Calls on Congress to Close …
WEB5 days ago · Washington, D.C., September 19, 2024 – The ERISA Industry Committee (“ERIC”) today released a new issue brief, “PBM Reform: Deem PBMs a “Fiduciary” Under ERISA,” calling for Pharmacy Benefit Managers (“PBMs”) to be deemed a “fiduciary” under the Employee Retirement Income Security Act (“ERISA”).The issue brief details how …
Lawmakers unveil PBM reform bill amid rising drug costs
WEBJul 23, 2024 · The new bill joins dozens of other bipartisan efforts on the federal and state level to reform PBMs, which negotiate rebates with drug manufacturers on behalf of insurers, large employers and ...
Pharmacy benefit managers profit at expense of patients and small ... - CNN
WEBJul 9, 2024 · Pharmacy benefit managers, which negotiate the terms for prescription drug access for hundreds of millions of Americans, are racking up profits while squeezing patients and independent...
How FTC's Battle With PBMs Could Reshape The Pharmaceutical ... - Forbes
WEBJul 20, 2024 · The FTC’s investigation of PBMs marks a pivotal moment in the ongoing effort to reform the healthcare industry and ensure that it serves the best interests of patients.
Why PBMs, or pharmacy benefit managers, are the focus of new ... - NPR
WEBJul 7, 2023 · At least nine bills introduced in Congress take aim at pharmacy benefit managers, the powerful middlemen that channel prescription drugs to patients. Here's what the fuss is all about.
House lawmakers slam pharmacy middlemen over sky-high drug …
WEBJul 23, 2024 · The House Committee on Oversight and Accountability heard testimony from the leaders of three pharmacy benefit managers, or PBMs, one month after the Federal Trade Commission released a scathing...
How PBMs Are Driving Up Prescription Drug Costs - The New York Times
WEBJun 21, 2024 · The three largest pharmacy benefit managers, or P.B.M.s, act as middlemen overseeing prescriptions for more than 200 million Americans.